High drug costs are often in the news.Consumer groups contend that the pricing for some drugs is "too high" considering that the costs to manufacture each dose in so low. They talk of price gouging and excessive profits.Pharmaceutical companies defend the price charged on the basis of nonmanufacturing costs such as research and development and others.

The following is a generic value chain for a pharmaceutical firm:

R and D Design Production Marketing Distribution